IP Library Granted Patent US 8,226,680
Granted Patent B2
US 8,226,680 · App. 12/873,008 · Granted Jul 24, 2012

System for embolizing a target site in a body by application of an external energy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,226,680
App. No.
12/873,008
Granted
Jul 24, 2012
Kind
B2
Abstract

A vaso-occlusive device is introduced in a cavity of a patient's vasculature, such as an aneurysm, after which an external energy source, such as a MRI machine is activated to heat the vaso-occlusive device to assist in forming a thrombus or embolism within the treatment site, to release and/or activate a diagnostic or therapeutic agent carried by the vaso-occlusive device, and/or to fuse together portions of the vaso-occlusive device to help stabilize the device in a three-dimensional shape.

Claims (23)

1. A system for embolizing a target site in a vasculature of a body, comprising:

a vaso-occlusive device detachably coupled to a distal end of a delivery wire insertable through a delivery catheter for deploying the vaso-occlusive device at a target site in a vasculature of a body, wherein the vaso-occlusive device is coated with a therapeutic bioactive agent, and additionally having a polymeric material coating substantially covering the bioactive agent coating; and

an external energy emitting device configured to deliver energy from a location outside the body to thereby heat the vaso-occlusive device after the vaso-occlusive device has been deployed at the target site in the body, wherein, when heated by energy emitted from the external energy emitting device, the polymeric material coating at least partially melts or softens so that the bioactive agent is released or activated at the target site.

2. The system of claim 1 , the target site comprising one of an aneurysm, a blood vessel lumen and a fistula.

3. The system of claim 1 , the external energy emitting device comprising a magnetic resonance device.

4. The system of claim 3 , wherein the vaso-occlusive device comprises a ferrous material in sufficient concentration to cause heating of the device in response to energy delivered by the magnetic resonance device.

5. The system of claim 1 , wherein the external energy emitting device comprises an ultrasound device configured to be acoustically coupled to an exterior surface of the body.

6. The system of claim 1 , wherein the external energy emitting device comprises a radio frequency energy generator.

7. A system for embolizing a target site in a body, comprising:

a vaso-occlusive device detachably coupled to a distal end of a delivery wire insertable through a delivery catheter for deploying the vaso-occlusive device at a target site in a vasculature of a body, the vaso-occlusive device comprising a highly resistive element that is heated by application of a magnetic field, the vaso-occlusive device further comprising a polymeric material exterior coating and a therapeutic bioactive agent underlying the polymeric material coating; and

a magnetic resonance imaging (“MRI”) device, wherein activating the MRI device to apply a variable magnetic field to the body after the vaso-occlusive device has been deployed at the target site heats the highly resistive element in the vaso-occlusive device, thereby at least partially melting or softening the polymeric material exterior coating on the vaso-occlusive device to release or activate the underlying therapeutic bioactive agent.

8. The system of claim 7 , wherein the vaso-occlusive device may be sufficiently heated by application of magnetic field energy to cause coagulation of blood at the target site.

9. The system of claim 7 , wherein the vaso-occlusive device is configured to assume a three-dimensional shape upon being deployed at the target site, and wherein the vaso-occlusive device may be sufficiently heated by application of magnetic field energy to at least partially melt and fuse together portions of the vaso-occlusive device to thereby stabilize the vaso-occlusive device in the three-dimensional shape.

10. A system for embolizing an aneurysm in a body, comprising:

a vaso-occlusive device detachably coupled to a delivery catheter to thereby deploy the vaso-occlusive device in an aneurysm, the device including:

a highly conductive coil forming a lumen; and

a highly resistive element at least partially disposed in the coil lumen,

wherein the coil is coated with a therapeutic bioactive agent, and additionally

coated with a polymeric material substantially covering the bioactive agent,

such that applying magnetic field energy to the device from an energy emitting element located outside of the body would thereby heat the highly resistive element and, by way of convective heat transfer from the highly resistive element, heat the coil to thereby at least partially melt or soften the polymeric material coating to release or activate the bioactive agent.

11. The system of claim 10 , the coil comprising platinum; the highly resistive element comprising ferrous material.

12. The system of claim 10 , wherein the vaso-occlusive device may be sufficiently heated by application of energy from a source external to the body to cause coagulation of blood at the target site.

13. The system of claim 10 , wherein the vaso-occlusive device is configured to assume a three-dimensional shape upon being deployed at the target site, and wherein the vaso-occlusive device may be sufficiently heated by application of energy from a source external to the body to at least partially melt and fuse together portions of the vaso-occlusive device to thereby stabilize the vaso-occlusive device in the three-dimensional shape.

Assignments (7)
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052861/0001 →
CHANGE OF NAME Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC
Reel/Frame 052860/0716 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014. Recorded Mar 8, 2016
From: STRYKER MEDTECH LIMITED
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 038043/0011 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT. Recorded Mar 8, 2016
From: STRYKER NV OPERATIONS LIMITED
To: STRYKER MEDTECH LIMITED
Reel/Frame 038039/0001 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 23, 2015
From: STRYKER NV OPERATIONS LIMITED
To: STRYKER MEDTECH LIMITED
Reel/Frame 037153/0034 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 23, 2015
From: STRYKER MEDTECH LIMITED
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 037153/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2011
From: BOSTON SCIENTIFIC SCIMED, INC.
To: STRYKER CORPORATION; STRYKER NV OPERATIONS LIMITED
Reel/Frame 025977/0284 →